Category: Uncategorized

normal vs alzheimers brain

Telomerase Gene Therapy: Bolstering our fight against Alzheimer’s Disease

13 November 2018

Telomeres are the sentinels of our genes. These genetic sequences sit at the end of our chromosomes guarding them from the ravages of age...

Read more

Liz Parrish joins forces with his holiness the Dalai Lama to discuss ‘Sickness, Aging & Death’ – part of a dialogue on compassion & technology

14 September 2018

Introduction On 15th September 2018, Liz Parrish will join forces with His Holiness The Dalai Lama to discuss the topic of ‘Sickness, Aging and...

Read more

New Telomere Length Results – A 2018 Update by Liz Parrish

24 August 2018

Do not go gentle into that good night, Old age should burn and rave at close of day; Rage, rage against the dying of...

Read more

Liz Parrish: Paving the way in cutting edge gene therapy innovations to treat diseases of aging

2 August 2018

Recently, an article was published on the website Outside publicising Liz Parrish, founder of BioViva, a company focused on health and longevity. BioViva believes that it is on the...

Read more
alzheimers

A Novel Gene Therapy To Treat One Of The World’s Biggest Growing Chronic Disease: Dementia and Alzhiemer’s

17 July 2018

Research studies indicate that telomerase gene therapy may not only reverse Alzheimer’s Disease and other dementias, but it may even protect people from developing...

Read more

Bioviva: Helping reduce the burden of chronic aging

11 July 2018

What BioViva does as a company is vitally important. Throughout our lifetime, it is possible to achieve amazing things, but time is always a...

Read more

What prompted Elizabeth Parrish to set up BioViva?

4 July 2018

2013 was a difficult year for Elizabeth Parrish. Upon finding out that her son had type 1 diabetes. A condition with dangerous continuations of...

Read more
No Images

BioViva’s aims to be an advanced medicinal product access platform. To this end BioViva is committed to the following:

17 May 2018

Bridging stakeholders with biotechnology Accelerated path to human trials Growing knowledge base Ensuring dependability BioViva is a platform to expedite the development of drugs...

Read more

Overexpression of genes to suppress dsRNA innate immunity

8 March 2018

BioViva scientist Ali Fallah et al have worked on the reprogramming potential of GCS (germline derived stem cells) the self-renewal capacity of which makes...

Read more